NIME PHARMACEUTICALS INC.
TAMPA, FLORIDA

NIME PHARMACEUTICALS INC., TAMPA

NIME PHARMACEUTICALS INC. is an Active company incorporated on May 25, 2022 with the registered number P22000043751. This Domestic for Profit company is located at 900 WEST PLATT STREET, SUITE#200, TAMPA, FL, 33606-2173, US and has been running for three years. There are currently three active principals.

KEY FACTS ABOUT NIME PHARMACEUTICALS INC.

  1. US Businesses
  2. Companies in Florida
  3. Hillsborough County Companies
Company name
NIME PHARMACEUTICALS INC.
Status
Active
Filed Number
P22000043751
FEI Number
88-2647627
Date of Incorporation
May 25, 2022
Age - 3 years
Home State
FL
Company Type
Domestic for Profit

NIME PHARMACEUTICALS INC. NEAR ME

Principal Address
900 WEST PLATT STREET,
SUITE#200,
TAMPA,
FL,
33606-2173,
US

See Also

NIMDA AVIATION, INC. NIMDEC TECHNICAL SOLUTIONS, LLC NIMECO VIRTUAL SOLUTIONS, LLC NIMEL MEDICAL CENTER LLC NIMER1039 LLC

Officers and Directors

The NIME PHARMACEUTICALS INC. managed by the three persons from TAMPA on following positions: Director, CFO, Vice President

Jonnie Rsr. Williams

Position
Director Active
From
TAMPA, 33606
Jonnie Rsr. Williams Related Companies
  1. SUPERA PHARMACEUTICALS, INC.
  2. SUPERA RESEARCH & DEVELOPMENT LLC
  3. MYVET PHARMACEUTICALS, INC.
  4. REVOLOGIC PHARMACEUTICALS, INC.
  5. SRQ PATENT HOLDINGS II LLC
  6. MYRIDINE INC.
Find More →

James A Mcnulty

Position
CFO Active
From
TAMPA, 33606
James A Mcnulty Related Companies
  1. BIOTECH SPECIALTY PARTNERS, LLC
  2. JORDAN RIVER BIOPHARMACEUTICALS, INC.
  3. PUTT4AMERICA, LLC
  4. BLACK ROBE CAPITAL, LLC
  5. HEDGEPATH, LLC
  6. NICOBINE MANAGEMENT INCORPORATED
Find More →

William J Mcnulty

Position
Vice President Active
From
TAMPA, 33606
William J Mcnulty Related Companies
  1. SUPERA AVIATION I LLC
  2. SUPERA PHARMACEUTICALS, INC.
  3. SUPERA RESEARCH & DEVELOPMENT LLC
  4. SUPERA AVIATION II LLC
  5. SETACYBIN INC.
  6. OXYGENE INC.
Find More →



Registered Agent is James A Mcnulty

From
TAMPA, 33606

Annual Reports

2024
April 3, 2024
2023
April 12, 2023